Browsing by Author Luo, Feng Roger
Showing results 1 to 2 of 2
Issue Date | Title | Author(s) |
2014 | Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting | Luo, Feng Roger; Ding, Jian; Chen, Helen X.; Liu, Hao; Fung, Man-Cheong; Koehler, Maria; Armand, Jean Pierre; Jiang, Lei; Xu, Xiao; Zhang, Ge; Xu, Li; Qian, Pascal; Yan, Li |
2019 | Safety and efficacy of abivertinib (AC0010), a third-generation EGFR tyrosine kinase inhibitor, in Chinese patients with EGFR-T790M positive non-small cell lung cancer (NCSLC). | Zhou, Qing; Wu, Lin; Feng, Luo; An, Tongtong; Cheng, Ying; Zhou, Jianying; Li, Junling; Feng, Ji Feng; Zhang, Li; Han, Baohui; Xu, Walson; Zhu, Lvyu; Xu, Li; Xu, Xiao; Luo, Feng Roger; Wu, Yi-Long |